STIM · NASDAQ
Neuronetics (STIM) Stock Price & Fundamentals
Neuronetics (STIM) closed at $707.84 on Oct 9, 2026, down 0.18% from the previous close of $709.10.
Share price, past year
1Y +21.32%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $707.84 |
| Sep 30, 2026 | $710.47 |
| Aug 31, 2026 | $700.32 |
| Jul 31, 2026 | $700.79 |
| Jun 30, 2026 | $708.14 |
| May 29, 2026 | $667.04 |
| Apr 30, 2026 | $651.06 |
| Mar 31, 2026 | $657.15 |
| Feb 27, 2026 | $623.45 |
| Jan 30, 2026 | $610.00 |
| Dec 31, 2025 | $588.79 |
| Nov 28, 2025 | $608.80 |
| Oct 31, 2025 | $575.93 |
Key statistics
- Market cap
- $53.93B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.44
- Revenue (TTM)
- $155.10M
- Net income (TTM)
- −$30.43M
- Shares outstanding
- 76.2M
- Dividend yield
- —
- 52-week range
- $565.22 – $728.92
Neuronetics's market cap is $53.93B, based on a share price of $707.84 and 76.2M shares outstanding as of Jun 30, 2026.
Financials
Neuronetics reported revenue of $149.16M for fiscal 2025, up 99.17% from fiscal 2024.
Neuronetics reported a net loss of $39.00M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $149.16M | +99.2% | −$39.00M | −26.2% | −$0.59 | — |
| FY2024ended Dec 31, 2024 | $74.89M | +5.0% | −$43.71M | −58.4% | −$1.38 | — |
| FY2023ended Dec 31, 2023 | $71.35M | +9.4% | −$30.19M | −42.3% | −$1.05 | — |
| FY2022ended Dec 31, 2022 | $65.21M | +17.9% | −$37.16M | −57.0% | −$1.38 | — |
| FY2021ended Dec 31, 2021 | $55.31M | +12.3% | −$31.19M | −56.4% | −$1.22 | — |
| FY2020ended Dec 31, 2020 | $49.24M | −21.4% | −$27.45M | −55.8% | −$1.46 | — |
| FY2019ended Dec 31, 2019 | $62.66M | +18.7% | −$29.04M | −46.4% | −$1.58 | — |
| FY2018ended Dec 31, 2018 | $52.78M | +30.5% | −$24.10M | −45.7% | −$2.69 | — |
| FY2017ended Dec 31, 2017 | $40.43M | +18.1% | −$16.06M | −39.7% | −$86.34 | — |
| FY2016ended Dec 31, 2016 | $34.23M | — | −$11.23M | −32.8% | −$76.95 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $41.57M | −$3.44M | −$0.05 |
| Q1 FY2026ended Mar 31, 2026 | $34.45M | −$10.79M | −$0.16 |
| Q4 FY2025ended Dec 31, 2025 | $41.78M | −$7.16M | −$0.10 |
| Q3 FY2025ended Sep 30, 2025 | $37.30M | −$9.05M | −$0.13 |
| Q2 FY2025ended Jun 30, 2025 | $38.11M | −$10.12M | −$0.15 |
| Q1 FY2025ended Mar 31, 2025 | $31.98M | −$12.68M | −$0.21 |
| Q4 FY2024ended Dec 31, 2024 | $22.49M | −$12.66M | −$0.34 |
| Q3 FY2024ended Sep 30, 2024 | $18.53M | −$13.34M | −$0.44 |
Company profile
- Name
- Neuronetics, Inc.
- Ticker
- STIM
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 3222 Phoenixville Pike, Malvern, PA 19355
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001227636
Recent SEC filings
- Aug 17, 2026
- Aug 11, 2026
- Aug 11, 2026
- Jul 20, 2026
- Jun 23, 2026
- May 29, 2026
- May 22, 2026
- May 5, 2026
Frequently asked questions
What is Neuronetics's stock price?
Neuronetics (STIM) closed at $707.84 on Oct 9, 2026, down 0.18% from the previous close of $709.10.
What is Neuronetics's market cap?
Neuronetics's market cap is $53.93B, based on a share price of $707.84 and 76.2M shares outstanding as of Jun 30, 2026.
How much revenue does Neuronetics make?
Neuronetics reported revenue of $149.16M for fiscal 2025, up 99.17% from fiscal 2024.
Does Neuronetics pay a dividend?
Neuronetics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Neuronetics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures